Xueran Chen

1.5k total citations
45 papers, 1.1k citations indexed

About

Xueran Chen is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Xueran Chen has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in Xueran Chen's work include Epigenetics and DNA Methylation (10 papers), Glioma Diagnosis and Treatment (9 papers) and Ferroptosis and cancer prognosis (6 papers). Xueran Chen is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Glioma Diagnosis and Treatment (9 papers) and Ferroptosis and cancer prognosis (6 papers). Xueran Chen collaborates with scholars based in China and France. Xueran Chen's co-authors include Zhiyou Fang, Chenggang Zhao, Haoran Yang, Hongzhi Wang, Lei Hu, Huihui Ma, Haiming Dai, Meng Chen, Xiaoqing Fan and Shangrong Zhang and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xueran Chen

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueran Chen China 19 729 320 162 136 119 45 1.1k
Haoran Yang China 14 374 0.5× 233 0.7× 114 0.7× 52 0.4× 78 0.7× 29 671
Timothy Nacarelli United States 19 917 1.3× 285 0.9× 245 1.5× 260 1.9× 68 0.6× 25 1.6k
Teresa L. Mastracci United States 21 585 0.8× 194 0.6× 190 1.2× 78 0.6× 78 0.7× 38 1.2k
Svetlana Zonis United States 19 564 0.8× 226 0.7× 326 2.0× 68 0.5× 75 0.6× 27 1.3k
János Haskó Hungary 17 390 0.5× 149 0.5× 260 1.6× 150 1.1× 48 0.4× 23 1.1k
Emily Foulstone United Kingdom 18 1.2k 1.7× 214 0.7× 153 0.9× 77 0.6× 212 1.8× 30 1.7k
Xiuping Zhou China 24 976 1.3× 299 0.9× 253 1.6× 115 0.8× 467 3.9× 74 1.6k
Jorge Navarro‐Dorado Spain 16 479 0.7× 227 0.7× 412 2.5× 106 0.8× 41 0.3× 30 950

Countries citing papers authored by Xueran Chen

Since Specialization
Citations

This map shows the geographic impact of Xueran Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueran Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueran Chen more than expected).

Fields of papers citing papers by Xueran Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueran Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueran Chen. The network helps show where Xueran Chen may publish in the future.

Co-authorship network of co-authors of Xueran Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xueran Chen. A scholar is included among the top collaborators of Xueran Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueran Chen. Xueran Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chang, Yue, Rui Du, Fan Xia, et al.. (2024). Dysregulation of Fatty Acid Metabolism in Breast Cancer and Its Targeted Therapy. Breast Cancer Targets and Therapy. Volume 16. 825–844. 4 indexed citations
3.
Zhang, Siyu, et al.. (2023). Blocking Palmitoylation of Apelin Receptor Alleviates Morphine Tolerance in Neuropathic Cancer Pain. International Journal of Biological Sciences. 20(1). 47–60. 7 indexed citations
4.
Chen, Xueran, Meng Cheng, Jiajia Zhao, et al.. (2023). Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression. Cell Death and Disease. 14(6). 383–383. 16 indexed citations
5.
Fan, Xiaoqing, et al.. (2023). Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation. Molecular Neurobiology. 60(6). 3452–3463. 7 indexed citations
6.
Fan, Xiaoqing, Haoran Yang, Huihui Ma, et al.. (2022). SETD2 Palmitoylation Mediated by ZDHHC16 in Epidermal Growth Factor Receptor-Mutated Glioblastoma Promotes Ionizing Radiation-Induced DNA Damage. International Journal of Radiation Oncology*Biology*Physics. 113(3). 648–660. 25 indexed citations
7.
Zhao, Chenggang, Xiaoqing Fan, Wanxiang Niu, et al.. (2022). GSK3β palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2–STAT3 axis. Oncogenesis. 11(1). 28–28. 23 indexed citations
8.
Qi, Jian, Chenggang Zhao, Wanxiang Niu, et al.. (2022). Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma. BMC Cancer. 22(1). 885–885. 3 indexed citations
9.
Bian, Erbao, Xueran Chen, Li Cheng, et al.. (2021). Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc. Journal of Experimental & Clinical Cancer Research. 40(1). 337–337. 27 indexed citations
10.
Fan, Xiaoqing, Haoran Yang, Chenggang Zhao, et al.. (2021). Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation. Stem Cell Research & Therapy. 12(1). 107–107. 36 indexed citations
11.
Fan, Xiaoqing, Delong Wang, Xueran Chen, & Ruiting Wang. (2020). <p>Effects of Anesthesia on Postoperative Recurrence and Metastasis of Malignant Tumors</p>. Cancer Management and Research. Volume 12. 7619–7633. 8 indexed citations
12.
Chen, Xueran, Xiaoqing Fan, Chenggang Zhao, et al.. (2020). Protein Palmitoylation Regulates Cell Survival by Modulating XBP1 Activity in Glioblastoma Multiforme. Molecular Therapy — Oncolytics. 17. 518–530. 31 indexed citations
13.
Bian, Erbao, Xueran Chen, Yadi Xu, et al.. (2019). A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma. Journal of Experimental & Clinical Cancer Research. 38(1). 366–366. 12 indexed citations
14.
Ma, Huihui, Chenggang Zhao, Zhiyang Zhao, et al.. (2019). Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns. Cancer Gene Therapy. 27(9). 702–714. 25 indexed citations
15.
Chen, Xueran, Lei Hu, Haoran Yang, et al.. (2019). DHHC protein family targets different subsets of glioma stem cells in specific niches. Journal of Experimental & Clinical Cancer Research. 38(1). 25–25. 47 indexed citations
16.
Chen, Xueran, Aijun Hao, Xian Li, et al.. (2019). Activation of JNK and p38 MAPK Mediated by ZDHHC17 Drives Glioblastoma Multiforme Development and Malignant Progression. Theranostics. 10(3). 998–1015. 56 indexed citations
17.
Chen, Xueran, Huihui Ma, Zhen Wang, et al.. (2017). EZH2 Palmitoylation Mediated by ZDHHC5 in p53-Mutant Glioma Drives Malignant Development and Progression. Cancer Research. 77(18). 4998–5010. 92 indexed citations
18.
Chen, Xueran, Wenjuan Zhou, Xinyue Li, et al.. (2017). Effect of melatonin on neuronal differentiation requires CBP/p300-mediated acetylation of histone H3 lysine 14. Neuroscience. 364. 45–59. 28 indexed citations
19.
Du, Zhaoxia, et al.. (2016). Protein palmitoylation activate zygotic gene expression during the maternal-to-zygotic transition. Biochemical and Biophysical Research Communications. 475(2). 194–201. 4 indexed citations
20.
Wang, Chen, Xueran Chen, Wei Shi, et al.. (2015). 2-Bromopalmitate impairs neural stem/progenitor cell proliferation, promotes cell apoptosis and induces malformation in zebrafish embryonic brain. Neurotoxicology and Teratology. 50. 53–63. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026